Drug Regulation: Investigating the Investigator

For only the second time in its history, the Food and Drug Administration last week struck a physician's name from its approved list of researchers who are entitled to test new, investigational drugs on human subjects. The target of the FDA's action was Dr. Albert M. Kligman, a Philadelphia dermatologist, along with "all investigators associated with" three incorporated laboratories of which he is president and director.

Only last year Dr. Kligman, a full professor in the University of Pennsylvania School of Medicine, published what was then hailed as "the most thorough study...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!